newsfilter
← Latest News
Business Wire·

AVROBIO to Present at the H.C. Wainwright Global Investment Conference

AVROBIO, Inc. (NASDAQ:AVRO), a leading clinical-stage gene therapy company with a shared purpose to free people from a lifetime of genetic disease, today announced members of its senior management team will be presenting virtually at the H.C. Wainwright